Cargando…
Population-based outcome of muscle-invasive bladder cancer following radical cystectomy: who can benefit from adjuvant chemotherapy?
BACKGROUND: The benefit of adjuvant chemotherapy remains controversial in muscle-invasive bladder cancer (MIBC) after radical cystectomy. The present study’s primary objective was to construct a predictive tool for the reasonable application of adjuvant chemotherapy. METHODS: All of the patients ana...
Autores principales: | Tian, Junjie, Sun, Junjie, Fu, Guanghou, Xu, Zhijie, Chen, Xiaoyi, Shi, Yue, Jin, Baiye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844522/ https://www.ncbi.nlm.nih.gov/pubmed/33532324 http://dx.doi.org/10.21037/tau-20-960 |
Ejemplares similares
-
Selection of patients and benefit of immediate radical cystectomy for non-muscle invasive bladder cancer
por: Pang, Karl H., et al.
Publicado: (2019) -
Does Time to Adjuvant Chemotherapy after Radical Cystectomy Affect Survival in Muscle Invasive Bladder Cancer? A Systematic Review
por: Kronstedt, Shane, et al.
Publicado: (2022) -
Activation of cGAS-STING Signal to Inhibit the Proliferation of Bladder Cancer: The Immune Effect of Cisplatin
por: Fu, Guanghou, et al.
Publicado: (2022) -
Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer: A retrospective multicenter study
por: Orré, Mathieu, et al.
Publicado: (2017) -
RCC1 functions as a tumor facilitator in clear cell renal cell carcinoma by dysregulating cell cycle, apoptosis, and EZH2 stability
por: Wu, Yunfei, et al.
Publicado: (2023)